Design and Analysis of Clinical Study 10. Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.

Slides:



Advertisements
Similar presentations
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
Advertisements

Study Designs in Epidemiologic
Mother and Child Health: Research Methods G.J.Ebrahim Editor Journal of Tropical Pediatrics, Oxford University Press.
Biostatistics ~ Types of Studies. Research classifications Observational vs. Experimental Observational – researcher collects info on attributes or measurements.
Intermediate methods in observational epidemiology 2008 Instructor: Moyses Szklo Measures of Disease Frequency.
Measure of disease frequency
Vietnam Osteoporosis Workshop, HCMC 2006 RISK FACTORS FOR OSTEOPOROTIC FRACTURE IN THE ELDERLY Tuan Van Nguyen and Nguyen Dinh Nguyen Garvan Institute.
Measures of association
Nemours Biomedical Research Statistics April 23, 2009 Tim Bunnell, Ph.D. & Jobayer Hossain, Ph.D. Nemours Bioinformatics Core Facility.
Cohort Studies.
Introduction to Logistic Regression Analysis Dr Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Epidemiology Kept Simple
Measures of Morbidity. Morbidity and Mortality Weekly Reports.
Main Points to be Covered Cumulative incidence using life table method Difference between cumulative incidence based on proportion of persons at risk and.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
HaDPop Measuring Disease and Exposure in Populations (MD) &
COHORT STUDY DR. A.A.TRIVEDI (M.D., D.I.H.) ASSISTANT PROFESSOR
Incidence and Prevalence
Are exposures associated with disease?
Cohort Study.
Lecture 3: Measuring the Occurrence of Disease
Multiple Choice Questions for discussion
Design and Analysis of Clinical Study Odds ratio and relative risk Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Prospective Study Cohort Study Assis.Prof.Dr Diaa Marzouk Community Medicine.
Identification of individuals at high- risk of fracture Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
Estimation of Various Population Parameters Point Estimation and Confidence Intervals Dr. M. H. Rahbar Professor of Biostatistics Department of Epidemiology.
Design and Analysis of Clinical Study 8. Cross-sectional Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Retrospective Cohort Study. Review- Retrospective Cohort Study Retrospective cohort study: Investigator has access to exposure data on a group of people.
Lecture 6 Objective 16. Describe the elements of design of observational studies: (current) cohort studies (longitudinal studies). Discuss the advantages.
Genetic-Environmental Interaction: Implications for Osteoporosis Prevention Strategies.
Design and Analysis of Clinical Study 11. Analysis of Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Design and Analysis of Clinical Study 6. Case-control Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Logistic regression. Analysis of proportion data We know how many times an event occurred, and how many times did not occur. We want to know if these.
Design and Analysis of Clinical Study 2. Bias and Confounders Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
MBP1010 – Lecture 8: March 1, Odds Ratio/Relative Risk Logistic Regression Survival Analysis Reading: papers on OR and survival analysis (Resources)
Chapter 2 Nature of the evidence. Chapter overview Introduction What is epidemiology? Measuring physical activity and fitness in population studies Laboratory-based.
Rates, Ratios and Proportions and Measures of Disease Frequency
Measures of Association and Impact Michael O’Reilly, MD, MPH FETP Thailand Introductory Course.
Leicester Warwick Medical School Health and Disease in Populations Case-Control Studies Paul Burton.
© Department of Statistics 2012 STATS 330 Lecture 20: Slide 1 Stats 330: Lecture 20.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Osteoporosis: Measuring the Problem
A preliminary exploration into the Binomial Logistic Regression Models in R and their potential application Andrew Trant PPS Arctic - Labrador Highlands.
Applied Statistics Week 4 Exercise 3 Tick bites and suspicion of Borrelia Mihaela Frincu
Prediction of Hip Fracture in Elderly Men and Women by Fall-related Factors ND Nguyen, C Pongchaiyakul, JR Center, JA Eisman, TV Nguyen Bone and Mineral.
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
Measures of Disease Frequency
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Design and Analysis of Clinical Study 7. Analysis of Case-control Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
© Department of Statistics 2012 STATS 330 Lecture 22: Slide 1 Stats 330: Lecture 22.
CHP400: Community Health Program - lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Cohort Study Present: Disease Past: Exposure.
HCV Co-infection is Associated with a High Risk of Osteoporotic Fractures Among HIV Patients Roger Bedimo, MD; Henning Drechsler, MD; Song Zhang, PhD;
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
A short introduction to epidemiology Chapter 2: Incidence studies Neil Pearce Centre for Public Health Research Massey University Wellington, New Zealand.
R Programming/ Binomial Models Shinichiro Suna. Binomial Models In binomial model, we have one outcome which is binary and a set of explanatory variables.
EPI 5344: Survival Analysis in Epidemiology Week 6 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine, University of Ottawa 03/2016.
Measures of disease frequency Simon Thornley. Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological.
Lecture 21: poisson regression log-linear regression BMTRY 701 Biostatistical Methods II.
Chapter 9: Case Control Studies Objectives: -List advantages and disadvantages of case-control studies -Identify how selection and information bias can.
Logistic regression.
A priori violations In the following cases, your data violates the normality and homoskedasticity assumption on a priori grounds: (1) count data  Poisson.
Present: Disease Past: Exposure
بسم الله الرحمن الرحيم COHORT STUDIES.
Some Epidemiological Studies
Lecture 1: Fundamentals of epidemiologic study design and analysis
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Epidemiology MPH 531 Analytic Epidemiology Cohort Studies
Measurements of Risk & Association …
Summary of Measures and Design
Presentation transcript:

Design and Analysis of Clinical Study 10. Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia

Uses of Cohort Study Identification of risk factors (or prognostic factors)? Uses of risk factors (or prognostic factors) Relation of risk measures to risk factors “It is estimated that smoking is responsible for 100,000 deaths from lung cancer annually”.

Risk Risk = –Prospective chance (probability) –Rate of occurrence (incidence) of a health- related event Measures of risk –Incidence density (including mortality rate) –Cumulative incidence(including "attack rate") –Case-fatality rate –Survival rate

Criteria to be Fulfilled in Cohort Studies Observation must take place over a meaningful period of time All members of the cohort must be observed. Drop-outs distort the study.

Types of Cohort Past PresentFuture Concurrent Cohort Assembled now Followed into future Historical Cohort Assembled from past records Followed till now Retrospective Cohort Exposure and outcome

Analysis of Cohort Studies Exposed Time Diseased (n=39) Healthy Not exposed Diseased (n=6) Healthy n = n =

-Medication: Corticosteroids Modifiable risk factors Non-modifiable risk factors Fracture - Bone-related factors: BMD, bone strength indice… - Fall and fall-related factors - Prior fracture - Lifestyle: smoking, alcohol - Advancing age - Family history - Genetics Intervention strategies Identify high-risk group

Prospective Cohort Study

Basal cohort(s)  Sampling from defined population, or  Stratified assembly, or  Matched assembly Observation for defined period under specified observational protocol Time of data collection: prospective vs. Retrospective cohort studies

Prospective Cohort Study

Factors in Prospective cohort study Event (e.g. disease) Person at risk, population at risk Person-years

Population at risk (N=200)        

Week 1         O O

Week 2         O O O O O

Week 3         O O O O O O O

Person-time Person-time = # persons x duration Time (week) Incidence rate (IR). During ( )=20 person-years, there were 2 incident cases: IR = 2/20 = o x

Estimation of Incidence Rates Consider a study where P patient-years have been followed and N cases (eg deaths, survivors, diseased, etc.) were recorded. Assumption: Poisson distribution. The estimate of incidence rate is: I = N / P Standard error of I is: 95% confidence interval of “true” incidence rate: I x SD(I)

Relative Risk Incidence rate of ischemic heart disease (IHD) 2750 kcal _____________________________________________________________ _ Person-years New cases _____________________________________________________________ _ Estimate rate SD of est. rate Relative risk (RR): L = log(RR) = Standard error of log(RR) 95% of L: L ± 1.96xSE = ± 1.96x = , % of RR: = exp(0.3055), exp(1.51) = 1.36, 4.53

Analysis of Difference in Incidence Rates Incidence rate of ischemic heart disease (IHD) 2750 kcal _____________________________________________________________ _ Person-years New cases _____________________________________________________________ _ Estimate rate SD of est. rate Difference: D = 15.1 – 6.1 = 8.93 Standard error (SE) of D 95% of D = D ± 1.96xSE = 8.93 ± 1.96x0.032 = 3.65, 14.2

Logistic Regression Analysis using R fracture <- read.table(“fracture.txt”, header=TRUE, na.string=”.”) attach(fulldata) results <- glm(fx ~ bmd, family=”binomial”) summary(results) Deviance Residuals: Min 1Q Median 3Q Max Coefficients: Estimate Std. Error z value Pr(>|z|) (Intercept) bmd (Dispersion parameter for binomial family taken to be 1) Null deviance: on 136 degrees of freedom Residual deviance: on 135 degrees of freedom AIC:

Incidence Density Number of new cases ID = ––––––––––––––––––– Population time Number of new cases 7 ID = ––––––––––––––––––– = –––––– Population time ?

Incidence Rate Population time at risk: –200 people for 3 weeks = 600 person-wks –But 2 people became cases in 1st week 3 people became cases in 2nd week 2 people became cases in 3rd week Only 193 people at risk for 3 weeks

Incidence Rate Population-time: –2 people who became cases in 1st week were at risk for 0.5 weeks each = 0.5 = 1.0 –3 people who became cases in 2nd week were at risk for 1.5 weeks each = 1.5 = 4.5 –2 people who became cases in 3rd week were at risk for 2.5 weeks each = 2.5 = 5.0 –Non-cases = 3 = 579 –TOTAL POPULATION – TIME = Person-weeks Incidence rate: 7 ID = –––––– = cases / person-wk average over 3 weeks

Incidence Proportion 7 3-week CI = –––– = Number of new cases CI = ––––––––––––––––––– Population at risk

Summary of Cohort Study’s Results Exposure statusTotal childrenDeveloped disease (disabled) Incidence Low ApgarN1N1 X1X1 I 1 = X 1 /N 1 High ApgarN2N2 X2X2 I 2 = X 2 /N 2 Relative risk (RR) = I 1 / I 2

Person-time Person-time = # persons x duration Time Incidence rate (IR). During ( )=20 person-years, there were 2 incident cases: IR = 2/20 =

Incidence

Estimation of Incidence Rates Consider a study where P patient-years have been followed and N cases (eg deaths, survivors, diseased, etc.) were recorded. Assumption: Poisson distribution. The estimate of incidence rate is: I = N / P Standard error of I is: 95% confidence interval of “true” incidence rate: I x SD(I)

Relative Risk Incidence rate of ischemic heart disease (IHD) 2750 kcal _____________________________________________________________ _ Person-years New cases _____________________________________________________________ _ Estimate rate SD of est. rate Relative risk (RR): L = log(RR) = Standard error of log(RR) 95% of L: L ± 1.96xSE = ± 1.96x = , % of RR: = exp(0.3055), exp(1.51) = 1.36, 4.53

Analysis of Difference in Incidence Rates Incidence rate of ischemic heart disease (IHD) 2750 kcal _____________________________________________________________ _ Person-years New cases _____________________________________________________________ _ Estimate rate SD of est. rate Difference: D = 15.1 – 6.1 = 8.93 Standard error (SE) of D 95% of D = D ± 1.96xSE = 8.93 ± 1.96x0.032 = 3.65, 14.2

Logistic Regression Analysis using R fracture <- read.table(“fracture.txt”, header=TRUE, na.string=”.”) attach(fulldata) results <- glm(fx ~ bmd, family=”binomial”) summary(results) Deviance Residuals: Min 1Q Median 3Q Max Coefficients: Estimate Std. Error z value Pr(>|z|) (Intercept) bmd (Dispersion parameter for binomial family taken to be 1) Null deviance: on 136 degrees of freedom Residual deviance: on 135 degrees of freedom AIC:

Dubbo Osteoporosis Epidemiology Study 1989 – 1993: –Recruit 3000 individuals –Measure bone mineral density (BMD) –Classified BMD into normal and osteoporosis 1989 – 2005: –Record the number of fractures –Analysis of association between BMD and fracture

Dubbo Osteoporosis Epidemiology Study 1287women Low BMD 345 (27%) Not Low BMD 942 (73%) Fx = 137 (40%) No Fx = 208 (60%) No Fx = 751 (80%) Fx = 191 (20%) 42%

Advantages and Disadvantages of Cohort Studies Direct calculation of incidence Time sequence can be established Different outcomes for one agent can be determined Large numbers to be measured over a long time Subclinical disease may escape diagnosis Advantages Disadvantages